Pharmacokinetics of chlorofluorocarbon and hydrofluoroalkane metered-dose inhaler formulations of beclomethasone dipropionate

This publication has 7 references indexed in Scilit:

• Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma
  Respiratory Medicine, 1999
• Hydrofluoroalkane-134a Beclomethasone Dipropionate, 400 μg, Is as Effective as Chlorofluorocarbon Beclomethasone Dipropionate, 800 μg, for the Treatment of Moderate Asthma
  Chest, 1999
• Dose Response to Inhaled Corticosteroids: Benefits and Risks
  Seminars in Respiratory and Critical Care Medicine, 1998
• Improved delivery of inhaled steroids to the large and small airways
  Respiratory Medicine, 1998
• Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose
  Respiratory Medicine, 1998
• Pharmacokinetics of inhaled drugs
  British Journal of Clinical Pharmacology, 1996
• Use of Spacers to Facilitate Inhaled Corticosteroid Treatment of Asthma^1–4
  American Review of Respiratory Disease, 1984